Detail

Chr	chr3
start	188151206
end	188154057
lncRNA name	MYCLo-5
entrez id	339929
hgnc id	HGNC:27952
ensg id	ENSG00000270959
refseq id	NR_036497
methods	qPCR, Flow cytometry assay, Cell proliferation assay etc.
regulated	down-regulated
function description	Of the tested cell lines, MYCLo-4 was upregulated by MYC knockdown in HCT116 (CRC), RKO (CRC), HT29 (colorectal adenocarcinoma), A549 (Lung carcinoma) and PC3 (prostate cancer). The other 2 lncRNAs, MYCLo-5 and -6 were also induced by MYC repression in various cancer types such as CRC (HCT116, RKO and HT29), lung cancer (A549), prostate cancer (PC3), breast cancer (MCF7 and SKBR3) and hepatocellular carcinoma (SK-HEP-1 and HepG2).
pubmed id	26003165
year	2015
title	MYC-repressed long noncoding RNAs antagonize MYC-induced cell proliferation and cell cycle progression.
drug	X
circulating	X
survival	X
Chr	chr3
start	188151206
end	188154057
lncRNA name	MYCLo-5
entrez id	339929
hgnc id	HGNC:27952
ensg id	ENSG00000270959
refseq id	NR_036497
methods	qPCR, Flow cytometry assay, Cell proliferation assay etc.
regulated	down-regulated
function description	Of the tested cell lines, MYCLo-4 was upregulated by MYC knockdown in HCT116 (CRC), RKO (CRC), HT29 (colorectal adenocarcinoma), A549 (Lung carcinoma) and PC3 (prostate cancer). The other 2 lncRNAs, MYCLo-5 and -6 were also induced by MYC repression in various cancer types such as CRC (HCT116, RKO and HT29), lung cancer (A549), prostate cancer (PC3), breast cancer (MCF7 and SKBR3) and hepatocellular carcinoma (SK-HEP-1 and HepG2).
pubmed id	26003165
year	2015
title	MYC-repressed long noncoding RNAs antagonize MYC-induced cell proliferation and cell cycle progression.
drug	X
circulating	X
survival	X